UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spinal and supraspinal N -methyl- d -aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia

Physiology & behavior, 2015-08, Vol.147, p.364-372

2015

Volltextzugriff (PDF)

A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans

British journal of clinical pharmacology, 2022-01, Vol.88 (1), p.347-355

2022

Volltextzugriff (PDF)

Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study

Journal of women's health (Larchmont, N.Y. 2002), 2018-08, Vol.27 (8), p.1035-1044

2018

Volltextzugriff (PDF)

Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations

CNS drugs, 2015-06, Vol.29 (6), p.465-486

2015

Volltextzugriff (PDF)

The influence of drug class on reward in substance use disorders

Pharmacology, biochemistry and behavior, 2024-07, Vol.240, p.173771-173771, Article 173771

2024

Volltextzugriff (PDF)

Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients

Psychopharmacology, 2019-10, Vol.236 (10), p.2857-2866

2019

Volltextzugriff (PDF)

Morphine-6β-glucuronide Rapidly Increases Pain Sensitivity Independently of Opioid Receptor Activity in Mice and Humans

Anesthesiology (Philadelphia), 2009-06, Vol.110 (6), p.1356-1363

2009

Volltextzugriff (PDF)

Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations

CNS drugs, 2015-06, Vol.29 (6), p.465-486

2015

Volltextzugriff (PDF)

Rates and Correlates of Pain Specialty Clinic Use Nationally in the Veterans Health Administration

Pain medicine (Malden, Mass.), 2017-04, Vol.18 (4), p.702-710

2017

Volltextzugriff (PDF)

Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Nature Medicine, 2023-06, Vol.29 (6), p.1487-1499

2023

Volltextzugriff (PDF)

5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers

Addiction biology, 2021-07, Vol.26 (4), p.e12993-n/a

2021

Volltextzugriff (PDF)

Rates and correlates of specialized pain clinic use nationally in the veterans health administration

Drug and alcohol dependence, 2017-02, Vol.171, p.e10-e11

2017

Volltextzugriff (PDF)

C-Fos activation in the periaqueductal gray following acute morphine-3β- d -glucuronide or morphine administration

Physiology & behavior, 2014-05, Vol.130, p.28-33

2014

Volltextzugriff (PDF)

Thiopental Does Not Produce Hyperalgesia: A Laboratory Study Using Two Human Experimental Pain Models

Pain medicine (Malden, Mass.), 2020-11, Vol.21 (11), p.2823-2829

2020

Volltextzugriff (PDF)

Effect of Intravenous Ethanol on Capsaicin-Induced Hyperalgesia in Human Subjects

Alcoholism, clinical and experimental research, 2016-07, Vol.40 (7), p.1425-1429

2016

Volltextzugriff (PDF)

Acute and chronic heroin dependence in mice: Contribution of opioid and excitatory amino acid receptors

European journal of pharmacology, 2008-05, Vol.586 (1), p.179-188

2008

Volltextzugriff (PDF)

A survey of acute and chronic heroin dependence in ten inbred mouse strains: Evidence of genetic correlation with morphine dependence

Pharmacology, biochemistry and behavior, 2008-09, Vol.90 (3), p.447-452

2008

Volltextzugriff (PDF)

Signaling-specific inhibition of the CB 1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Nature medicine, 2023-06, Vol.29 (6), p.1487

2023

Volltextzugriff (PDF)

Supraspinal and spinal mechanisms of morphine-induced hyperalgesia

Arout, Caroline A

2014

Volltextzugriff (PDF)

Human Laboratory Models of Cannabis Use Disorder

Cannabis Use Disorders, 2018, p.75-84

2018

Volltextzugriff (PDF)

Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans

Anesthesiology (Philadelphia), 2009-06, Vol.110 (6), p.1356

2009

Volltextzugriff (PDF)

CHANGES IN ANALGESIC AND ABUSE-RELATED EFFECTS OF CANNABIS WITH REPEATED ADMINISTRATION IN HUMANS

Drug and alcohol dependence, 2024-07, Vol.260, p.110023, Article 110023

2024

Volltextzugriff (PDF)

Acute effects of cannabinoids on symptoms of obsessive‐compulsive disorder: A human laboratory study

Depression and anxiety, 2020-08, Vol.37 (8), p.801-811

2020

Volltextzugriff (PDF)

The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study

Molecular psychiatry, 2023-06, Vol.28 (6), p.2462-2468

2023

Volltextzugriff (PDF)

Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City

Preventive medicine, 2023-07, Vol.172, p.107533, Article 107533

2023

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(31)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Spinal and supraspinal N -methyl- d -aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia

A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans

Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study

Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations

The influence of drug class on reward in substance use disorders

Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients

Morphine-6β-glucuronide Rapidly Increases Pain Sensitivity Independently of Opioid Receptor Activity in Mice and Humans

Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations

Rates and Correlates of Pain Specialty Clinic Use Nationally in the Veterans Health Administration

Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

5HT‐2C agonist lorcaserin decreases cannabis self‐administration in daily cannabis smokers

Rates and correlates of specialized pain clinic use nationally in the veterans health administration

C-Fos activation in the periaqueductal gray following acute morphine-3β- d -glucuronide or morphine administration

Thiopental Does Not Produce Hyperalgesia: A Laboratory Study Using Two Human Experimental Pain Models

Effect of Intravenous Ethanol on Capsaicin-Induced Hyperalgesia in Human Subjects

Acute and chronic heroin dependence in mice: Contribution of opioid and excitatory amino acid receptors

A survey of acute and chronic heroin dependence in ten inbred mouse strains: Evidence of genetic correlation with morphine dependence

Signaling-specific inhibition of the CB 1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Supraspinal and spinal mechanisms of morphine-induced hyperalgesia

Human Laboratory Models of Cannabis Use Disorder

Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans

CHANGES IN ANALGESIC AND ABUSE-RELATED EFFECTS OF CANNABIS WITH REPEATED ADMINISTRATION IN HUMANS

Acute effects of cannabinoids on symptoms of obsessive‐compulsive disorder: A human laboratory study

The impact of preexisting psychiatric disorders and antidepressant use on COVID-19 related outcomes: a multicenter study

Racial differences in COVID-19 severity associated with history of substance use disorders and overdose: Findings from multi-site electronic health records in New York City

Suchergebnisse filtern